Pancreatic cancer is one of the most lethal and molecularly diverse malignancies. Repurposing of therapeutics that target specific molecular mechanisms in different disease types offers potential for rapid improvements in outcome. Although HER2 amplification occurs in pancreatic cancer, it is…
Source:Clinical and molecular characterization of HER2 amplified pancreatic cancer
Saturday, August 31, 2013
Clinical and molecular characterization of HER2 amplified pancreatic cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment